Michelle Parisien

Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups

Oscar M. Rueda, Stephen‐John Sammut, José A. Seoane et al. · Nature · 2019 · 452 citations · Full text

Medicine, Genetics, Oncology +9

Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.

Sandra Troup, Catherine Njue, Erich V. Kliewer et al. · PubMed · 2003 · 239 citations

Medicine, Cancer Biology, Oncology +16

Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research

Rebecca Barnes, Michelle Parisien, Leigh C. Murphy et al. · Cancer Epidemiology Biomarkers & Prevention · 2008 · 58 citations

Medicine, Oncology, Translational Sciences +14

The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research.

Peter H. Watson, Luke B. Snell, Michelle Parisien · PubMed · 1996 · 47 citations

Medicine, Cancer Biology, Oncology +10

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomas

G. Skliris, Brian G. Rowan, Mariam Al-Dhaheri et al. · Breast Cancer Research and Treatment · 2008 · 38 citations

Medicine, Endocrinology, Oncology +17